tiprankstipranks

Joseph Truitt Insider Profile

4 Followers
Joseph Truitt, CEO, Director at Achillion Pharmaceuticals, holds 0.00 shares in Achillion Pharmaceuticals (Ticker: ~ACHN), holds ― shares in Biospecifics Technologies (Ticker: BSTC), holds 2.75K shares in Larimar Therapeutics (Ticker: LRMR).
tipranks
Joseph Truitt

Joseph Truitt
Achillion Pharmaceuticals (~ACHN)
CEO, Director

Ranked #39,018 out of 98,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+21.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$20K
100.00%
A breakdown of Joseph Truitt's holdings

Insider Roles

Larimar Therapeutics
(LRMR)
Director
Roles that Joseph Truitt holds in companies

Most Profitable Insider Trade

Stock:
Larimar Therapeutics
(LRMR)
Rating:Informative Buy
Date:May 18, 2023 - Today
Return:+70.80%
The most profitable trade made by Joseph Truitt

Joseph Truitt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ACHN
Achillion Pharmaceuticals
Jan 29, 2020
Uninformative Sell
22.05K
$0.00
BSTC
Biospecifics Technologies
Larimar Therapeutics
May 18, 2023
Director
Informative Buy
10.26K
$20.21K
List of latest transactions for each holding click on a transaction to see Joseph Truitt's performance on stock

Joseph Truitt insider profile FAQ

What is the percentage of profitable transactions made by Joseph Truitt?
The percentage of profitable transactions made by Joseph Truitt is 50%.
    What is the average return per transaction made by Joseph Truitt?
    The average return per transaction made by Joseph Truitt is 21.20%.
      What stocks does Joseph Truitt hold?
      Joseph Truitt holds: ~ACHN, BSTC, LRMR stocks.
        What was Joseph Truitt’s latest transaction?
        Joseph Truitt latest transaction was an Uninformative Sell of $22.05K.
          What was Joseph Truitt's most profitable transaction?
          Joseph Truitt’s most profitable transaction was an Informative Buy of LRMR stock on May 18, 2023. The return on the trade was 70.80%.
            What is Joseph Truitt's role in Achillion Pharmaceuticals?
            Joseph Truitt's role in Achillion Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.